文献速递间质性肺疾病

线粒体抗病毒信号蛋白在肺纤维化发生中起关键作用

Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis.
PubMed 文献 · Eur Respir J · 2021-04-15

该研究利用博来霉素诱导的肺纤维化模型,发现线粒体抗病毒信号蛋白(MAVS)是多条损伤相关分子模式(DAMP)信号通路及随后肺纤维化的关键介导因子,MAVS主要在巨噬细胞中表达且多聚化增强并持续存在;BH3模拟物ABT-263可减弱MAVS及其信号表达并减轻实验性肺纤维化,而尼达尼布和吡非尼酮的疗效与MAVS调控无关;IPF患者肺内MAVS多聚化亦显著增加。

要点

  • MAVS是多条DAMP信号通路及博来霉素诱导肺纤维化的关键介导因子。
  • BH3模拟物ABT-263可减弱MAVS表达与信号,减轻实验性肺纤维化。
  • 尼达尼布和吡非尼酮的疗效与MAVS或其信号的调控无关。

核心结论

  • MAVS可能在肺纤维化发生中起重要作用,以BH3模拟物靶向MAVS或为IPF提供新的治疗策略。

研究设计与样本

  • 采用已建立的博来霉素诱导肺纤维化模型开展体内研究,观察MAVS在损伤后肺内的表达与多聚化。

主要发现

  • 博来霉素损伤后MAVS表达主要见于巨噬细胞。
  • 博来霉素损伤肺内MAVS多聚化聚集显著增加并持续存在。
  • ABT-263减弱MAVS及其信号表达,并抑制实验性肺纤维化的发展。
  • 尼达尼布和吡非尼酮的疗效与MAVS或其信号调控无关。
  • IPF患者肺内MAVS多聚化聚集亦显著增加。

临床怎么用

  • 提示MAVS信号通路可作为IPF潜在治疗靶点,BH3模拟物值得进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Danger signals, or damage-associated molecular patterns (DAMPs), instigate mitochondrial innate immune responses wherein mitochondrial antiviral signaling protein (MAVS) functions as a key platform molecule to mediate them. The role of MAVS in the pathogenesis of idiopathic pulmonary fibrosis (IPF), however, has not yet been identified. Whether MAVS signalling can be modulated by currently existing drugs has also not been explored.We used an established model of pulmonary fibrosis to demonstrate that MAVS is a critical mediator of multiple DAMP signalling pathways and the consequent lung fibrosis after bleomycin-induced injury in vivoAfter bleomycin injury, MAVS expression was mainly observed in macrophages. Multimeric MAVS aggregation, a key event of MAVS signalling activation, was significantly increased and persisted in bleomycin-injured lungs. A proapoptotic BH3 mimetic, ABT-263, attenuated the expression of MAVS and its signalling and, consequently, the development of experimental pulmonary fibrosis. In contrast, the therapeutic effects of nintedanib and pirfenidone, two drugs approved for IPF treatment, were not related to the modulation of MAVS or its signalling. Multimeric MAVS aggregation was significantly increased in lungs from IPF patients as well.MAVS may play an important role in the development of pulmonary fibrosis, and targeting MAVS with BH3 mimetics may provide a novel and much needed therapeutic strategy for IPF.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kim SH, Lee JY, Yoon CM, et al. Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis. Eur Respir J. 2021. PMID: 33093124. doi:10.1183/13993003.00652-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。